K. Turner

发表

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Charles C Wykoff, Adrian L Harris, A. Harris, 2002, Cancer cell.

A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful?

A. Harris, D. McGrouther, K. Turner, 2004, Clinical & Experimental Metastasis.

Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

S. Fox, A. Harris, M. Currie, 2001, Cancer research.

Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

P H Watson, A. Harris, P. Watson, 2000, Cancer research.

Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.

A. Harris, C. Fujiyama, I. Stratford, 2002, The Journal of urology.

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer

A. Harris, P. Watson, R. Poulsom, 2002, British Journal of Cancer.

Elevated serum vascular endothelial growth factor in patients with hormone‐escaped prostate cancer

C. Fujiyama, S. Fuggle, D. Cranston, 2000, BJU international.

Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

A. Harris, P. Ratcliffe, C. Taylor, 2002, Cancer research.

Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis

C. Fujiyama, S. Fuggle, H. Turley, 2000, BJU international.

Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia

A. Harris, Cheng Han, M. Currie, 2002, The Journal of pathology.

Expression of Hypoxia-inducible Factors in Human Renal Cancer : Relationship to Angiogenesis and to the von Hippel-Lindau Gene Mutation 1

A. Harris, P. Ratcliffe, C. Taylor, 2002 .